Apr 21 / 2026

Rubell Museum – Miami, Florida

Where LATAM Biotech Meets Global Opportunity
A curated summit connecting breakthrough biotech startups from Latin America with global investors, industry leaders, and innovation experts-focused on scaling science for human and planetary health.

Powered by:
The Ganesha Lab
LATAM’s leading biotech scale-up platform

DISCOVER • connect • impact

The Gateway to LATAM’s Most Promising Biotech Innovations.

This isn’t just another conference—it’s a launchpad for global biotech solutions.

Why Biohunt Summit?

Because bold biotech from Latin America deserves a global stage—and the right partners to scale faster.

Curated LATAM Innovation

Access 20+ vetted biotech startups from across Latin America.

Global Matchmaking

Meet 150+ investors, industry execs, and innovation leaders from the US and Europe.

Real-World Impact

Solutions in health, food, longevity, and sustainability.

Premium Format

Live Dolphin Tanks, demo tables, expert panels, and the Rubell Museum experience.

A Proven Platform for Biotech Breakthroughs.

With 35% annual growth, funded startups, and hundreds of curated
investor meetings, BioHunt Summit delivers real-world results—not just connections.

BioHunt Summit delivers results—and 2026 will be our most ambitious edition yet.

STARTUPS

Xeptiva Therapeutics

Clinical-stage company developing first-in-class therapeutic vaccines for the treatment of chronic conditions in companion animals. We have developed a safer, longer-lasting and cost-effective alternative that trains the pet’s immune system to heal itself.

3D Armour

3D Armour is transforming orthopedic care with next-generation 3D-printed immobilizers. Our precision-scanned, Nylon 12 devices are lightweight, breathable, and customized, offering a superior alternative to plaster and fiberglass casts.

Unibaio

Unibaio develops biodegradable delivery technology that boosts fungicide performance, cutting chemical use by 30–60% while maintaining or increasing yields. TurboCharge™ improves delivery efficiency without changing farming practices, generating immediate ROI and scalable licensing opportunities.

Vali

Developing AI-powered software to accelerate cytogenetics, the branch of genetics that studies chromosomes. Historically slow, often taking weeks, Vali is already enabling clinical and research labs to cut analysis turnaround times by over 50%.

Cor.Sync

Cor.Sync provides a fast and accurate solution for myocardial infarction diagnosis in emergency rooms, enabling troponin measurement directly from whole blood in just 8 minutes, with laboratory-level accuracy and cost.

Qnity Bio

Qnity develops quantum electrochemical sensing technology that enables ultra-sensitive, label-free measurement of molecular interactions, delivering faster insights for drug discovery and diagnostics with minimal samples.

SciTherm Therapeutics

SciTherm Therapeutics a new approach to fat loss with oral therapeutics that activate the body’s natural fat-burning pathways to treat obesity and metabolic disorders.

Peptidus

We use an AI-powered platform to accelerate peptide drug discovery for animal health therapies.

MetaBIX Biotech

MetaBIX Biotech leverages biotechnology and AI to predict diseases through an integrated biosurveillance platform combining air sampling, molecular diagnostics, and advanced analytics. Its technology delivers early risk alerts, enabling faster preventive decisions and greater resilience across animal production and food supply chains.

Sticta

Precision fermentation platform producing recombinant proteins and growth factors for cultivated meat and agriculture.

Sante Science

Innovative biotechnology that uses upcycling to produce natural ingredients which enhance treatment and reduce the side effects of oncological chemotherapy in humans and pets — improving quality of life, longevity, gut and immune health

Eywa

Empowering global research to develop more effective and lasting mental health treatments.

Amplify Dynamics

Ensuring ultrapure supply of lipid nanoparticles, accelerating the development of life-saving treatments

Tell Toolkit

Revolutionary early detection of neurodegenerative disorders through speech-based technology.

Telica

Using the natural power of the Quassia amara plant to create next-gen botanical insecticides – highly effective, pollinator-safe, and ready to replace chemicals.

Berking Biotechnology

Developing Unique single chain recombinant antibodies from Camelids to block viral entry into Canine parvovirus host

Southerly

Transforming fruit export packaging with a natural additive reducing rot, bleaching, and chemical residues for a safer, more sustainable path for global fruit exporters.

Southerly

Transforming fruit export packaging with a natural additive reducing rot, bleaching, and chemical residues for a safer, more sustainable path for global fruit exporters.

Berking Biotechnology

Developing Unique single chain recombinant antibodies from Camelids to block viral entry into Canine parvovirus host

Telica

Using the natural power of the Quassia amara plant to create next-gen botanical insecticides – highly effective, pollinator-safe, and ready to replace chemicals.

Tell Toolkit

Revolutionary early detection of neurodegenerative disorders through speech-based technology.

Amplify Dynamics

Ensuring ultrapure supply of lipid nanoparticles, accelerating the development of life-saving treatments

Eywa

Empowering global research to develop more effective and lasting mental health treatments.

Sante Science

Innovative biotechnology that uses upcycling to produce natural ingredients which enhance treatment and reduce the side effects of oncological chemotherapy in humans and pets — improving quality of life, longevity, gut and immune health

Sticta

Precision fermentation platform producing recombinant proteins and growth factors for cultivated meat and agriculture.

MetaBIX Biotech

MetaBIX Biotech leverages biotechnology and AI to predict diseases through an integrated biosurveillance platform combining air sampling, molecular diagnostics, and advanced analytics. Its technology delivers early risk alerts, enabling faster preventive decisions and greater resilience across animal production and food supply chains.

Peptidus

We use an AI-powered platform to accelerate peptide drug discovery for animal health therapies.

SciTherm Therapeutics

SciTherm Therapeutics a new approach to fat loss with oral therapeutics that activate the body’s natural fat-burning pathways to treat obesity and metabolic disorders.

Qnity Bio

Qnity develops quantum electrochemical sensing technology that enables ultra-sensitive, label-free measurement of molecular interactions, delivering faster insights for drug discovery and diagnostics with minimal samples.

Cor.Sync

Cor.Sync provides a fast and accurate solution for myocardial infarction diagnosis in emergency rooms, enabling troponin measurement directly from whole blood in just 8 minutes, with laboratory-level accuracy and cost.

Vali

Developing AI-powered software to accelerate cytogenetics, the branch of genetics that studies chromosomes. Historically slow, often taking weeks, Vali is already enabling clinical and research labs to cut analysis turnaround times by over 50%.

Unibaio

Unibaio develops biodegradable delivery technology that boosts fungicide performance, cutting chemical use by 30–60% while maintaining or increasing yields. TurboCharge™ improves delivery efficiency without changing farming practices, generating immediate ROI and scalable licensing opportunities.

3D Armour

3D Armour is transforming orthopedic care with next-generation 3D-printed immobilizers. Our precision-scanned, Nylon 12 devices are lightweight, breathable, and customized, offering a superior alternative to plaster and fiberglass casts.

Xeptiva Therapeutics

Clinical-stage company developing first-in-class therapeutic vaccines for the treatment of chronic conditions in companion animals. We have developed a safer, longer-lasting and cost-effective alternative that trains the pet’s immune system to heal itself.

SPEAKERS

Markus Schreyer

The Ganesha Fund

With a proven track record in scaling mission-driven ventures and fostering international collaborations, Markus has empowered biotech founders and reshaped innovation ecosystems from Europe, US to Latin America.

Michael Rossbach

Prof. Dr. Michael Rossbach is a global expert bridging science and business. With a PhD in Immunology from Harvard, he combines deep knowledge in genomics and cell-based therapeutics with leadership in venture capital and biotech strategy. He advises funds and companies worldwide, holds academic posts at leading institutions.

Dennis Ford

Life Science Nation

Dennis Ford is an entrepreneur, author, and sales/marketing expert focused on high-growth startups. He has launched companies, built markets for breakthrough technologies, and connects them with investors. As an advisor and author of acclaimed books, he shapes strategies for fundraising and business growth.

Galit Flasterstein

Danta Fund

Galit Flasterstein is a serial entrepreneur turned agtech investor. She has experienced both success and failure and knows first hand what entrepreneurs go through. That is why, when she created her fund, Danta Fund, her mission was to fill three main voids for agtech startups in Latam: early stage funding, mentorship from experts and connections to developed markets.

Stephen Chambers

SOS Ventures

Stephen Chambers is a founding scientist of Vertex Pharmaceuticals and co-founder of Abpro Therapeutics, with 22 years at the forefront of life sciences. As CEO of the UK Innovation & Knowledge Centre for Synthetic Biology, he helped catalyze a surge of startups and sector fundraising.

Diego Ibáñez

Botanical Solution

Industrial Civil Engineer from Universidad Adolfo Ibáñez with a Master of Business Administration from Macquarie Business School. With two decades of experience in finance and innovation, he drives growth at Botanical Solution as CFO and Territory Manager, shaping science-driven ventures across Chile and Latin America.

Eduardo Abeliuk

TeselaGen Biotechnology

A U.S. based entrepreneur with over twenty years of experience driving technology development and innovation. As a  startup leader and innovator from Stanford University, he is leading a California based company that works at the interface between Synthetic Biology, Artificial Intelligence and Enterprise Software. 

Roberto Braga Mendez

The Ganesha Lab

A purpose-driven leader focused on unlocking value in emerging markets, he drives strategies that combine innovation and sustainable growth within the healthcare ecosystem. His work centers on advancing personalized medicine, AI-driven discovery, and expanding access to care. Known for building strong, trust-based relationships, he fosters talent development and continuous improvement. Guided by integrity and impact, he is committed to supporting entrepreneurs and creating lasting value for society, businesses, and stakeholders.

Carlos Eduardo Gouvêa

Executive President, CBDL - The Brazilian In Vitro Diagnostic Association

Carlos Eduardo Gouvêa, Executive President of Brazil’s Chamber for In Vitro Diagnostics and holds key leadership and advisory positions across prominent healthcare and industry organizations in Latin America. With a background in law, public administration, and a global MBA, he has held leadership roles across multinational companies and now leads multiple ventures in health, nutrition, and technology.

Daniel Pimentel

Managing Patrner at Emerge

Daniel Pimentel is a Managing Partner at Emerge, where he has empowered over 5,000 scientists and founded 10+ deep tech startups to bridge the gap between scientific breakthroughs and the market. He leads strategic collaborations with major corporations and government agencies while driving the ecosystem forward through the Deep Tech Summit and specialized business development consulting

Renato Ramalho

CEO & Partner at KPTL

Founder and CEO of KPTL Investimentos, with extensive experience in leadership, strategy, and business development. KPTL has over 20 years of track record, more than 150 completed deals, and currently supports 70 investee companies, including over 20 in biotech and 50+ in deeptech in Brazil. Renato is driven by long-term value creation, disciplined execution, and the scaling of innovation-driven businesses.

Play Video

BUILDING BRIDGES & INDUSTRY NETWORK

TUESDAY, APR 21 / RUBELL MUSEUM

08:30 REGISTRATION & RECEPTION BREAKFAST
09:30 OPENING CEREMONY
Markus Schreyer – Managing Partner The Ganesha Fund
Francisco Chávez - VP and GM, Latin America en Thermo Fisher Scientific
10:00 KEYNOTE SPEAKER: AI-POWERING BIOTECH. Disrupting Disease, Food, and the Future
Prof Dr. Michael Rossbach – PhD Immunology from Harvard.
10:30 PANEL: BORN IN LATAM, BUILT FOR THE WORLD. Biotech Innovation Without Borders
A conversation with LATAM biotech founders who have successfully expanded into global markets, sharing the strategies, challenges, and milestones behind building world-class companies from the region.
11:30 DOLPHIN TANK
Founders present their solutions in a Dolphin Tank setting, where they receive constructive feedback from participating investors & industry experts.
13:00 NETWORKING BRUNCH AND STARTUP DEMO TABLES
14:00 DOLPHIN TANK
Founders present their solutions in a Dolphin Tank setting, where they receive constructive feedback from participating investors.
15:30 NETWORKING COFFEE BREAK AND STARTUP DEMO TABLE
Connect & explore powerful partnership opportunities while indulging a delightful coffee interval amidst the inspiring backdrop of the Rubell Museum.
16:00 FIRE SIDE CHAT: BUILDING THE GLOBAL BRIDGE. Latam Biotech’s Next Leap
Markus Schreyer – The Ganesha Lab
Dennis Ford – Life Science Nation
16:30 PANEL: LATAM BIOTECH. RETURNS WITH PURPOSE
Markus Schreyer – The Ganesha Lab
Dennis Ford – Life Science Nation
Galit Flasterstein - Dantafund
Stephen Chambers - SOS Ventures
17:15 PANEL: THE BRAZIL EFFECT. Capital, Innovation, and regional transformation
Roberto Braga Mendes– The Ganesha Lab
Renato Ramalho – KPTL Investimentos
Daniel Pimentel - EMERGE Brazil
Carlos Eduardo Gouvêa - CBDL
17.45 CLOSING REMARKS
Embracing the future of innovation.
18.00 VIP COCKTAIL & DRINKS AT RUBELL MUSEUM
Private cocktail to celebrate the relationships built during the event between startups, investors and experts.

SPONSORS PLATINUM

SPONSORS GOLDEN

SPONSORS SILVER

PARTNERS